CRISPR/Cas9—Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development

The clustered regularly interspaced short palindromic repeat (CRISPR)/associated protein 9 (Cas9) technology is revolutionizing genome editing approaches. Its high efficiency, specificity, versatility, flexibility, simplicity and low cost have made the CRISPR/Cas9 system preferable to other guided s...

Descripción completa

Detalles Bibliográficos
Autores principales: Okoli, Arinze, Okeke, Malachy I., Tryland, Morten, Moens, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795463/
https://www.ncbi.nlm.nih.gov/pubmed/29361752
http://dx.doi.org/10.3390/v10010050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795463/
https://www.ncbi.nlm.nih.gov/pubmed/29361752
http://dx.doi.org/10.3390/v10010050

Ejemplares similares